Literature DB >> 25273374

Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.

V H Le1, M Inai, R M Williams, T Kan.   

Abstract

The ecteinascidin family comprises a number of biologically active compounds, containing two to three tetrahydroisoquinoline subunits. Although isolated from marine tunicates, these compounds share a common pentacyclic core with several antimicrobial compounds found in terrestrial bacteria. Among the tetrahydroisoquinoline natural products, ecteinascidin 743 (Et-743) stands out as the most potent antitumor antibiotics that it is recently approved for treatment of a number of soft tissue sarcomas. In this article, we will review the backgrounds, the mechanism of action, the biosynthesis, and the synthetic studies of Et-743. Also, the development of Et-743 as an antitumor drug is discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25273374      PMCID: PMC4806878          DOI: 10.1039/c4np00051j

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  75 in total

1.  Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.

Authors:  Katia Scotlandi; Stefania Perdichizzi; Maria Cristina Manara; Massimo Serra; Stefania Benini; Vanessa Cerisano; Rosaria Strammiello; Mario Mercuri; Gemma Reverter-Branchat; Glynn Faircloth; Maurizio D'Incalci; Piero Picci
Journal:  Clin Cancer Res       Date:  2002-12       Impact factor: 12.531

2.  Total synthesis of cribrostatin IV: fine-tuning the character of an amide bond by remote control.

Authors:  Collin Chan; Richard Heid; Shengping Zheng; Jinsong Guo; Bishan Zhou; Takeshi Furuuchi; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2005-04-06       Impact factor: 15.419

3.  Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.

Authors:  D P Ryan; J G Supko; J P Eder; M V Seiden; G Demetri; T J Lynch; A J Fischman; J Davis; J Jimeno; J W Clark
Journal:  Clin Cancer Res       Date:  2001-02       Impact factor: 12.531

4.  High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer.

Authors:  H R Hendriks; H H Fiebig; R Giavazzi; S P Langdon; J M Jimeno; G T Faircloth
Journal:  Ann Oncol       Date:  1999-10       Impact factor: 32.976

5.  DC-52, a novel antitumor antibiotic. 1. Taxonomy, fermentation and biological activity.

Authors:  F Tomita; K Takahashi; K Shimizu
Journal:  J Antibiot (Tokyo)       Date:  1983-05       Impact factor: 2.649

6.  The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent.

Authors:  M Zewail-Foote; V S Li; H Kohn; D Bearss; M Guzman; L H Hurley
Journal:  Chem Biol       Date:  2001-11

Review 7.  Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.

Authors: 
Journal:  Drugs R D       Date:  2006

8.  A new Myxococcus xanthus gene cluster for the biosynthesis of the antibiotic saframycin Mx1 encoding a peptide synthetase.

Authors:  Andreas Pospiech; Bernard Cluzel; Jürg Bietenhader; Thomas Schupp
Journal:  Microbiology (Reading)       Date:  1995-08       Impact factor: 2.777

9.  Development of novel antioxidants: design, synthesis, and reactivity.

Authors:  Helmi H Hussain; Gordana Babic; Tony Durst; James S Wright; Mihaela Flueraru; Alexandru Chichirau; Leonid L Chepelev
Journal:  J Org Chem       Date:  2003-09-05       Impact factor: 4.354

10.  In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects.

Authors:  C Simoens; A E C Korst; C M J De Pooter; H A J Lambrechts; G G O Pattyn; G T Faircloth; F Lardon; J B Vermorken
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

View more
  22 in total

1.  Magnesium-Promoted Additions of Difluoroenolates to Unactivated Imines.

Authors:  Alex L Nguyen; Hari R Khatri; James R Woods; Cassidy S Baldwin; Frank R Fronczek; David A Colby
Journal:  J Org Chem       Date:  2018-02-27       Impact factor: 4.354

2.  Extracellularly oxidative activation and inactivation of matured prodrug for cryptic self-resistance in naphthyridinomycin biosynthesis.

Authors:  Yue Zhang; Wan-Hong Wen; Jin-Yue Pu; Man-Cheng Tang; Liwen Zhang; Chao Peng; Yuquan Xu; Gong-Li Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-16       Impact factor: 11.205

Review 3.  Natural products from thioester reductase containing biosynthetic pathways.

Authors:  Michael W Mullowney; Ryan A McClure; Matthew T Robey; Neil L Kelleher; Regan J Thomson
Journal:  Nat Prod Rep       Date:  2018-09-19       Impact factor: 13.423

4.  Chemometrics and genome mining reveal an unprecedented family of sugar acid-containing fungal nonribosomal cyclodepsipeptides.

Authors:  Chen Wang; Dongliang Xiao; Baoqing Dun; Miaomiao Yin; Adigo Setargie Tsega; Linan Xie; Wenhua Li; Qun Yue; Sibao Wang; Han Gao; Min Lin; Liwen Zhang; István Molnár; Yuquan Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-01       Impact factor: 12.779

Review 5.  Biomaterials and Bioactive Natural Products from Marine Invertebrates: From Basic Research to Innovative Applications.

Authors:  Giovanna Romano; Mariana Almeida; Ana Varela Coelho; Adele Cutignano; Luis G Gonçalves; Espen Hansen; Denis Khnykin; Tali Mass; Andreja Ramšak; Miguel S Rocha; Tiago H Silva; Michela Sugni; Loriano Ballarin; Anne-Marie Genevière
Journal:  Mar Drugs       Date:  2022-03-22       Impact factor: 6.085

6.  Characterization of Caerulomycin A as a dual-targeting anticancer agent.

Authors:  Lingying Tong; Weichao Sun; Shiyong Wu; Yong Han
Journal:  Eur J Pharmacol       Date:  2022-03-23       Impact factor: 5.195

Review 7.  Predominately Uncultured Microbes as Sources of Bioactive Agents.

Authors:  David J Newman
Journal:  Front Microbiol       Date:  2016-11-18       Impact factor: 5.640

Review 8.  Marine Natural Products from Tunicates and Their Associated Microbes.

Authors:  Chatragadda Ramesh; Bhushan Rao Tulasi; Mohanraju Raju; Narsinh Thakur; Laurent Dufossé
Journal:  Mar Drugs       Date:  2021-05-26       Impact factor: 5.118

Review 9.  Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem".

Authors:  Nelson G M Gomes; Ramesh Dasari; Sunena Chandra; Robert Kiss; Alexander Kornienko
Journal:  Mar Drugs       Date:  2016-05-21       Impact factor: 5.118

Review 10.  Ascidian Toxins with Potential for Drug Development.

Authors:  Dianne J Watters
Journal:  Mar Drugs       Date:  2018-05-13       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.